Cargando…
Treatment of type 2 diabetes with saxagliptin: a pharmacoeconomic evaluation in Argentina
BACKGROUND: The increasing prevalence of diabetes and its inadequate management results in a heavy burden of the disease for the patients, the health and the productive system and the overall community. Consequently, it is necessary to have new effective drugs to treat people with diabetes to decrea...
Autores principales: | Elgart, Jorge F, Caporale, Joaquin E, Gonzalez, Lorena, Aiello, Eleonora, Waschbusch, Maximiliano, Gagliardino, Juan J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651339/ https://www.ncbi.nlm.nih.gov/pubmed/23621944 http://dx.doi.org/10.1186/2191-1991-3-11 |
Ejemplares similares
-
The Burden of Diabetes in Argentina
por: González, Lorena, et al.
Publicado: (2015) -
Diabetes in Argentina: cost and management of diabetes and its complications and challenges for health policy
por: Caporale, Joaquín E, et al.
Publicado: (2013) -
Changes in quality of care and costs induced by implementation of a diabetes program in a social security entity of Argentina
por: González, Lorena, et al.
Publicado: (2013) -
Relation between cost of drug treatment and body mass index in people with type 2 diabetes in Latin America
por: Elgart, Jorge Federico, et al.
Publicado: (2017) -
Saxagliptin for type 2 diabetes
por: Chacra, Antonio R
Publicado: (2010)